- Guest post: FUMADERM and PML – can we make conclus…
- The INSPIRE Trial: the Charcot Project launches it…
- STREAMS TRIAL: stem cells in rapidly evolving acti…
- BG12 will cost $54,900 annually
- BG12 given the thumbs up: 1st line oral DMT
- PML and fumarates
- BG12 is effective within 12 weeks of starting trea…
- Pharma behaving badly in San Diego
- Cladribine CIS study
- CCSVI March 2013
“Can we learn anything from the most clicked on posts? Possibly! BG12 is clearly of interest in particular its safety; I note readers were particularly interested in the cases of PML on fumaderm. Trials are of interest; I am glad our INSPIRE trial is top of the pops – we are about to screen our first MSer for this trial. CCSVI still attracts attention but is clearly fading in interest. And what more can I say about Pharma behaving badly? Hopefully they will start behaving well; we need them to.”